packageOsimertinib

osimertinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Osimertinib is a third-generation EGFR tyrosine kinase inhibitor used to treat non-small-cell lung cancer with a specific mutation. It is approved and authorised in the European Union for non-small-cell lung carcinoma.

Summary written by glm-5.3-flash from Wikidata Q21506464 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:osimertinib
ATC codes:L01EB04, L01XE
DrugBank:DB09330
PubChem CID:71496458
ChEBI:90943
Wikidata:Q21506464
formula:C28H33N7O2
molar mass:499.619 g/mol (PubChem CID 71496458)
logP:3.7 (Drugs.Common 25.09, not verified)

Metabolites

AZ5104AZ5104485.592 g/mol (pubchem)
AZ7550AZ7550molar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
AZ5104metabolite: AZ5104
AZ7550metabolite: AZ7550